ChargePoint Technology, specialists in contained and sterile powder transfer solutions has announced the appointment of Kieran Coulton as Chairman.
Coulton is an accomplished leader in automation and manufacturing with a track record of 36 years in the industry. Having previously served as President Global Industry for GE Power Conversion, Kieran brings with him a wealth of experience and an ability to achieve excellent levels of business growth.
During his 27 years at Rockwell Automation Kieran gained extensive skills across management, sales, and marketing on a global scale. Coulton’s knowledge of diverse cultures, economics, pricing strategies and market access impacting US, EU and Asian markets put him in a great position to lead ChargePoint Technology into the next stage of growth.
“I am delighted to welcome Kieran to our fast-growing senior leadership team,” says Chris Eccles, CEO, ChargePoint Technology. “He is an asset to our business and his global leadership experience will be instrumental in scaling our services while maintaining operational efficiency and fulfilling customer requirements.”
Commenting on his appointment, Kieran adds: “I am honoured to be joining ChargePoint Technology during such an important time for the industry. I am looking forward to working with my colleagues to drive the company’s growth and new business strategies forward, while continuing to support the pharma industry to deliver critical medicines to patients all over the globe.”
ChargePoint Technology is the market leader in providing operator safety and sterility assurance for the pharmaceutical, biotech, chemical and other process industries. Its unique offering is its split butterfly valve (SBV) and single use transfer technology which is used in aseptic processing and during the manufacture of highly potent pharmaceutical products. It reduces the need for operator intervention and for cleaning and validating large areas, improving efficiencies during manufacturing.
About ChargePoint Technology
ChargePoint Technology is the trusted specialist for safe and reliable contained and sterile transfer solutions in the pharmaceutical, biotech, chemical and other process industries. Its client portfolio includes some of the top 25 pharmaceutical companies and reaches into North America, UK, Europe, China and India, amongst others.
ChargePoint Technology manufactures its cutting-edge devices in its purpose-built facility in Liverpool, UK, employs more than 80 employees across the globe and secured a multi-million pound investment from LDC, part of Lloyds Banking Group in January 2017, to meet the increase in global demand for its products and solutions.
